Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAGIC CELL-6-PRIMING STUDY
KCT0009268Phase 3Recruiting
- Sponsor
- Regenerative Medicine Foundation
- Start
- Jun 2024
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of angiopoietin-primed autologous peripheral blood stem cells in myocardial infarction (MI), sponsored by Regenerative Medicine Foundation. Started Jun 2024; status: recruiting.
02
Drugs
angiopoietin-primed autologous peripheral blood stem cells
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on KCT0009268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0009268.